Skip to main content
Clinical Trials/TCTR20210914003
TCTR20210914003
Not yet recruiting
Phase 1

Optimizing an mHealth intervention to improve uptake and adherence of the HIV pre-exposure prophylaxis (PrEP) among Thai young transgender women

IH0 sites200 target enrollmentSeptember 14, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
HIV pre-exposure prophylaxis (PrEP) among Thai young transgender women
Sponsor
IH
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2021
End Date
December 20, 2023
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
IH

Eligibility Criteria

Inclusion Criteria

  • 1\.Thai Nationality 2\.Age 18\-29 years old 3\.Male sex at birth 4\.Self\-identifies as woman or TGW or culturally identifies with the female spectrum 5\.Laboratory confirmed HIV negative status 6\.Self\-reported recent history of condomless sex 7\.Either not started PrEP (Group 1: PrEP naive) or currently on PrEP but not adherent (taking 3 pills/week) in the past month (Group 2: PrEP users)

Exclusion Criteria

  • 1\.A serious cognitive or psychiatric problem compromising ability to provide informed consent
  • 2\.Active suicidal ideation or major mental illness (e.g., untreated psychosis or mania) at the time of interview (patients will be referred for treatment) 3\.Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance) 4\.Currently enrolled in another HIV intervention study

Outcomes

Primary Outcomes

Not specified

Similar Trials